To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With or Without Giving Reversal Agent on Extubation, in Patients Receiving Single Shot of Atracurium , and to Observe Post Operative Residual Paralysis and Airway Reflexes in PACU.
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT07097441
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 100 participants
- Sponsor
- Ziauddin University
- Registry
-
NCT07097441
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Pakistan
- Registry status
- Completed
Technical summary
Registry record NCT07097441. Randomized; triple masking; primary purpose treatment. Start 2025-03-12 (actual); primary completion 2025-06-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With or Without Giving Reversal Agent on Extubation, in Patients Receiving Single Shot of Atracurium , and to Observe Post Operative Residual Paralysis and Airway Reflexes in PACU.
- Condition
- Tachycardia
- Condition
- Hypertension
- Condition
- Hypoxia
- Condition
- Hyperventilation
- Condition
- Residual Paralysis, Post Anesthesia
- Intervention (Drug)
- Placebo drug ( normal saline )
- Intervention (Drug)
- neostigmine (reversal agent)
- Lead sponsor
- Ziauddin University
Record details
- Record id
cardio:ct-nct07097441- Content hash
f43065e2f0a7a74f26d728a2f89cac295b2c80a76041f2259f63a6ee64728d3a